GCTK logo

GlucoTrack (GCTK) EBITDA

Annual EBITDA

-$7.09 M
-$2.68 M-60.83%

December 31, 2023


Summary


Performance

GCTK EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherGCTKprofitabilitymetrics:

Quarterly EBITDA

-$3.24 M
+$1.24 M+27.70%

September 30, 2024


Summary


Performance

GCTK Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherGCTKprofitabilitymetrics:

TTM EBITDA

-$13.09 M
-$1.03 M-8.55%

September 30, 2024


Summary


Performance

GCTK TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherGCTKprofitabilitymetrics:

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

GCTK EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-60.8%-34.1%-84.8%
3 y3 years-129.8%-328.7%-288.5%
5 y5 years-6.8%-440.2%-350.4%

GCTK EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-80.0%at low-250.8%+27.7%-232.3%at low
5 y5-year-129.8%at low-446.2%+27.7%-365.4%at low
alltimeall time-505.9%+30.7%-560.6%+56.9%-2347.3%at low

GlucoTrack EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
-$3.24 M(-27.7%)
-$13.09 M(+8.6%)
Jun 2024
-
-$4.48 M(+52.1%)
-$12.06 M(+37.8%)
Mar 2024
-
-$2.95 M(+21.9%)
-$8.75 M(+23.5%)
Dec 2023
-$7.09 M(+60.8%)
-$2.42 M(+9.4%)
-$7.08 M(+19.1%)
Sep 2023
-
-$2.21 M(+87.9%)
-$5.95 M(+27.6%)
Jun 2023
-
-$1.18 M(-8.1%)
-$4.66 M(+1.3%)
Mar 2023
-
-$1.28 M(-0.2%)
-$4.61 M(+4.4%)
Dec 2022
-$4.41 M(+11.9%)
-$1.28 M(+38.9%)
-$4.41 M(-3.4%)
Sep 2022
-
-$924.00 K(-17.4%)
-$4.56 M(+3.8%)
Jun 2022
-
-$1.12 M(+3.1%)
-$4.39 M(+6.2%)
Mar 2022
-
-$1.08 M(-24.5%)
-$4.14 M(+5.1%)
Dec 2021
-$3.94 M(+27.7%)
-$1.44 M(+89.9%)
-$3.94 M(+16.9%)
Sep 2021
-
-$756.00 K(-12.4%)
-$3.37 M(-3.4%)
Jun 2021
-
-$863.00 K(-2.4%)
-$3.49 M(+8.2%)
Mar 2021
-
-$884.00 K(+2.1%)
-$3.23 M(+4.5%)
Dec 2020
-$3.08 M(-10.7%)
-$866.00 K(-1.0%)
-$3.08 M(+9.7%)
Sep 2020
-
-$875.00 K(+45.8%)
-$2.81 M(-3.2%)
Jun 2020
-
-$600.00 K(-19.4%)
-$2.91 M(-8.9%)
Mar 2020
-
-$744.00 K(+25.4%)
-$3.19 M(-7.5%)
Dec 2019
-$3.46 M(-48.0%)
-$593.40 K(-38.7%)
-$3.45 M(-17.5%)
Sep 2019
-
-$968.50 K(+9.8%)
-$4.18 M(-12.5%)
Jun 2019
-
-$882.40 K(-12.1%)
-$4.78 M(-18.4%)
Mar 2019
-
-$1.00 M(-24.3%)
-$5.86 M(-12.3%)
Dec 2018
-$6.64 M(-35.2%)
-$1.33 M(-15.4%)
-$6.69 M(-16.4%)
Sep 2018
-
-$1.57 M(-20.2%)
-$7.99 M(-11.1%)
Jun 2018
-
-$1.96 M(+7.4%)
-$8.99 M(-6.0%)
Mar 2018
-
-$1.83 M(-30.6%)
-$9.56 M(-7.3%)
Dec 2017
-$10.24 M
-$2.63 M(+2.8%)
-$10.31 M(+17.2%)
DateAnnualQuarterlyTTM
Sep 2017
-
-$2.56 M(+1.1%)
-$8.80 M(+14.7%)
Jun 2017
-
-$2.53 M(-2.0%)
-$7.67 M(+14.4%)
Mar 2017
-
-$2.58 M(+130.9%)
-$6.70 M(+25.7%)
Dec 2016
-$5.33 M(-7.8%)
-$1.12 M(-22.1%)
-$5.33 M(-7.1%)
Sep 2016
-
-$1.44 M(-8.3%)
-$5.74 M(+6.5%)
Jun 2016
-
-$1.57 M(+29.2%)
-$5.39 M(-1.5%)
Mar 2016
-
-$1.21 M(-20.4%)
-$5.47 M(-5.4%)
Dec 2015
-$5.78 M(+61.8%)
-$1.52 M(+40.6%)
-$5.78 M(-50.2%)
Sep 2015
-
-$1.08 M(-34.4%)
-$11.60 M(+2.8%)
Jun 2015
-
-$1.65 M(+8.4%)
-$11.29 M(+7.4%)
Mar 2015
-
-$1.52 M(-79.3%)
-$10.52 M(+8.2%)
Dec 2014
-$3.57 M(-63.3%)
-$7.35 M(+850.8%)
-$9.72 M(-1.8%)
Sep 2014
-
-$772.60 K(-11.6%)
-$9.89 M(+0.5%)
Jun 2014
-
-$873.80 K(+20.3%)
-$9.84 M(+0.5%)
Mar 2014
-
-$726.50 K(-90.3%)
-$9.79 M(+0.5%)
Dec 2013
-$9.75 M(+254.6%)
-$7.52 M(+946.6%)
-$9.75 M(+244.3%)
Sep 2013
-
-$718.70 K(-12.8%)
-$2.83 M(+1.2%)
Jun 2013
-
-$824.10 K(+21.0%)
-$2.80 M(+2.8%)
Mar 2013
-
-$680.80 K(+12.2%)
-$2.72 M(+1.5%)
Dec 2012
-$2.75 M(+17.9%)
-$606.80 K(-11.5%)
-$2.68 M(-0.2%)
Sep 2012
-
-$686.00 K(-8.3%)
-$2.69 M(-0.3%)
Jun 2012
-
-$747.80 K(+16.6%)
-$2.69 M(+10.6%)
Mar 2012
-
-$641.50 K(+4.9%)
-$2.44 M(+4.6%)
Dec 2011
-$2.33 M(+69.9%)
-$611.30 K(-11.9%)
-$2.33 M(+35.6%)
Sep 2011
-
-$694.00 K(+41.5%)
-$1.72 M(+67.7%)
Jun 2011
-
-$490.60 K(-8.3%)
-$1.03 M(+91.7%)
Mar 2011
-
-$534.80 K
-$534.80 K
Dec 2010
-$1.37 M(+17.2%)
-
-
Dec 2009
-$1.17 M
-
-

FAQ

  • What is GlucoTrack annual EBITDA?
  • What is the all time high annual EBITDA for GlucoTrack?
  • What is GlucoTrack annual EBITDA year-on-year change?
  • What is GlucoTrack quarterly EBITDA?
  • What is the all time high quarterly EBITDA for GlucoTrack?
  • What is GlucoTrack quarterly EBITDA year-on-year change?
  • What is GlucoTrack TTM EBITDA?
  • What is the all time high TTM EBITDA for GlucoTrack?
  • What is GlucoTrack TTM EBITDA year-on-year change?

What is GlucoTrack annual EBITDA?

The current annual EBITDA of GCTK is -$7.09 M

What is the all time high annual EBITDA for GlucoTrack?

GlucoTrack all-time high annual EBITDA is -$1.17 M

What is GlucoTrack annual EBITDA year-on-year change?

Over the past year, GCTK annual EBITDA has changed by -$2.68 M (-60.83%)

What is GlucoTrack quarterly EBITDA?

The current quarterly EBITDA of GCTK is -$3.24 M

What is the all time high quarterly EBITDA for GlucoTrack?

GlucoTrack all-time high quarterly EBITDA is -$490.60 K

What is GlucoTrack quarterly EBITDA year-on-year change?

Over the past year, GCTK quarterly EBITDA has changed by -$824.00 K (-34.09%)

What is GlucoTrack TTM EBITDA?

The current TTM EBITDA of GCTK is -$13.09 M

What is the all time high TTM EBITDA for GlucoTrack?

GlucoTrack all-time high TTM EBITDA is -$534.80 K

What is GlucoTrack TTM EBITDA year-on-year change?

Over the past year, GCTK TTM EBITDA has changed by -$6.00 M (-84.78%)